Thursday - March 28, 2024
Sen. Baldwin Warns That Pharmaceutical Mergers May Increase Drug Prices, Reduce Patient Access to Essential Medications
September 17, 2019
WASHINGTON, Sept. 17 -- Sen. Tammy Baldwin, D-Wisconsin, issued the following news release:

In light of ongoing consolidation in the pharmaceutical sector, U.S. Senator Tammy Baldwin joined her Senate colleagues in calling on the Federal Trade Commission (FTC) to closely scrutinize pharmaceutical mergers that could increase prescription drug prices and reduce patient access to needed medications.

In a letter to FTC Chairman Joseph Simons led by Senator Amy Klobuchar (D- . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products